Chopra Daveen 4

What Happened
Daveen Chopra, CVP, TMTT & Surgical at Edwards Lifesciences, reported the sale of 1,500 shares on May 22, 2026. The shares were disposed at a weighted average price of $84.60 per share for total proceeds of approximately $126,905. The filing lists the transaction as an open-market or private sale (code S); sales are often routine and do not necessarily indicate a change in view about the company.

Key Details

• Transaction date: 2026-05-22
• Type: Sale (S) — reported as open market or private sale
• Price: Weighted average $84.60; executed in multiple trades at prices ranging $84.6002–$84.6050 (see footnote). The reporting person will provide a full breakdown on request.
• Shares sold: 1,500; proceeds ≈ $126,905
• Shares owned after transaction: Not specified in this Form 4 (filing notes it reflects changes in beneficial ownership only)
• Filing: Reported and filed on 2026-05-22 (appears timely)

Context
Insider sales can reflect many reasons (diversification, taxes, personal liquidity) and a single sale is not a clear negative signal by itself. This Form 4 does not show any option exercises, gifts, or 10% owner status; it only reports the change in beneficial ownership from this sale.